Philippe Pflieger

Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transport

Eric J. Niesor, Christine Magg, Naoto Ogawa et al. · Journal of Lipid Research · 2010 · 152 citations · Full text

Life Sciences, Biochemistry, Pharmacology +15

Mechanisms underlying off-target effects of the cholesteryl ester transfer protein inhibitor torcetrapib involve L-type calcium channels

Roger G. Clerc, Andrea Stauffer, Franziska Weibel et al. · Journal of Hypertension · 2010 · 64 citations

Medicine, Biochemistry, Pharmacology +14

Pyrimido[1,6-a]benzimidazoles: a new class of DNA gyrase inhibitors

Christian Hubschwerlen, Philippe Pflieger, Jean‐Luc Specklin et al. · Journal of Medicinal Chemistry · 1992 · 63 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Epoxidation of <i>cis</i> and <i>trans</i> Δ⁹‐unsaturated lauric acids by a cytochrome P‐450‐dependent system from higher plant microsomes

Jean‐Pierre Salaün, Daniel Weissbart, Francis Durst et al. · FEBS Letters · 1989 · 34 citations · Full text

Life Sciences, Biochemistry, Plant Biology +13

A pyrimido[1,6-a]benzimidazole that enhances DNA cleavage mediated by eukaryotic topoisomerase II: a novel class of topoisomerase II-targeted drugs with cytotoxic potential

Anita H. Corbett, Philippe Guerry, Philippe Pflieger et al. · Antimicrobial Agents and Chemotherapy · 1993 · 26 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15